COMMUNIQUÉS West-GlobeNewswire

Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

06/11/2024 - 22:05

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class [...]

Solid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Updates

06/11/2024 - 22:05

- Duchenne: Dosing completed for first three patients in INSPIRE DUCHENNE clinical trial; SGT-003 has been well tolerated in all patients with no SAEs observed; initial three patient data expected Q1 2025 - - Duchenne: [...]

Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results

06/11/2024 - 22:06

Expands pipeline of T cell engaging bispecific antibodies through acquisitions of CT-95, a Mesothelin x CD3 bispecific antibody, and CT-202, a Nectin-4 x CD3 bispecific antibody Strengthens board with appointments of Dr [...]

TerrAscend Reports Third Quarter 2024 Financial Results

06/11/2024 - 22:10

Net Revenue of $74.2 million and Gross Profit Margin of 48.8% 9 th consecutive quarter of positive Cash Flow from continuing operations and fifth consecutive quarter of positive Free Cash Flow 1 Closed on a senior [...]

Pennant Reports Third Quarter 2024 Results

06/11/2024 - 22:11

Conference Call and Webcast scheduled for tomorrow, November 7, 2024 at 10:00 am MT EAGLE, Idaho, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of [...]

Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update

06/11/2024 - 22:12

Reports Q3 2024 Total Revenues of $ 128.7 Million, Representing a 25.3 % YoY Increase Record Revenues Driven by Continued Organic Growth in its Rare Disease Franchise Robust Financial Performance Highlights Operational [...]

Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results

06/11/2024 - 22:15

Multiple clinical trial milestones were achieved, including encouraging topline data for a Phase 2 trial in CCM, the first patient dosed for a Phase 2 trial in recurrent C. difficile infection, and IND clearance for a [...]

Certara Reports Third Quarter 2024 Financial Results

06/11/2024 - 22:15

Updates Full Year 2024 Financial Guidance RADNOR, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the [...]

Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Development Program in Patients with Relapsed or Refractory EBV-Positive Peripheral T-Cell Lymphoma

06/11/2024 - 22:30

Company implementing 42% reduction in force and resizing its Board of Directors to six seats from ten SAN DIEGO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision [...]

MacroGenics to Participate in Upcoming Investor Conferences

06/11/2024 - 22:30

ROCKVILLE, MD, Nov. 06, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics [...]

SCYNEXIS Reports Third Quarter 2024 Financial Results and Provides Corporate Update

06/11/2024 - 22:30

Clinical study reports for the FURI, CARES and NATURE trials in refractory or resistant invasive fungal infections were delivered to GSK, triggering a $10 million development milestone payment to SCYNEXIS, received in [...]

Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

06/11/2024 - 22:30

DEER PARK, Ill., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the "Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare [...]

STERIS Announces Financial Results for Fiscal 2025 Second Quarter

06/11/2024 - 22:30

Total revenue from continuing operations increased 7%; constant currency organic revenue grew 7% As reported diluted EPS from continuing operations increased to $1.51; adjusted EPS increased to $2.14 Fiscal 2025 outlook [...]

Amedisys Reports Third Quarter 2024 Financial Results

06/11/2024 - 22:30

BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Three-Month Periods Ended September [...]

Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024

06/11/2024 - 22:30

IRVINE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients [...]

DBV Technologies publie ses résultats financiers du troisième trimestre 2024

06/11/2024 - 22:30

Châtillon, France, le 6 novembre (22 :30 CET) 2024 DBV Technologies publie ses résultats financiers du troisième trimestre 2024 DBV clôture le troisième trimestre 2024 avec un solde de trésorerie de 46,4 $ millions [...]

DBV Technologies Reports Third Quarter 2024 Financial Results

06/11/2024 - 22:30

Châtillon, France, November 6, 2024 DBV Technologies Reports Third Quarter 2024 Financial Results DBV closes Q3 2024 with a cash balance of $46.4 million; cash runway into Q1 2025 DBV Technologies (Euronext: DBV – ISIN [...]

Surrozen to Present at Upcoming Healthcare Investor Conferences

06/11/2024 - 22:30

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue [...]

BrightSpring Health Services Announces CareMed Was Selected as a National Specialty Pharmacy Partner for Leqembi®

06/11/2024 - 22:35

LOUISVILLE, Ky., Nov. 06, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud that CareMed, a BrightSpring company and leading independent [...]